A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
Clinical trial NCT03711162 · TERMINATED
Trial details
- NCT number
- NCT03711162
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2021-03-30
- Enrollment
- 525
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.